pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Phase 3
latarcibart
latarcibart [INN]
Von Willebrand Disease (vWD)
$STHO
Star Holdings
Phase 1
lecomkafusp alfa
lecomkafusp alfa [INN]
Adenocarcinoma Of The Gastroesophageal Junction
$HOWL
Werewolf Therapeutics, Inc.
Marketed
lefamulin acetate
Xenleta (lefamulin acetate)
Community-Acquired Bacterial Pneumonia
Nabriva Therapeutics US Inc
← prev
page 224 of 271
next →
Pain
89
Neurology
1
Phase 1
lefelsiran sodium
lefelsiran sodium
Alcohol Use Disorder (AUD)
Novo Nordisk AS
Phase 1
lefitolimod
lefitolimod [INN]
Solid Tumor
Mologen AG
Marketed
lemborexant
Dayvigo (lemborexant)
Insomnia
Eisai Co Ltd
Phase 2
lenacapavir + teropavimab + zinlirvimab
lenacapavir + teropavimab + zinlirvimab
Human Immunodeficiency Virus (HIV) Infections (AIDS)
$GILD
GILEAD SCIENCES, INC.
Phase 3
lenadogene nolparvovec
LUMEVOQ (lenadogene nolparvovec [INN])
Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy)
GenSight Biologics SA
Marketed
leniolisib
Joenja (leniolisib [INN])
Common Variable Immunodeficiency (CVID)
Pharming Group NV
Phase 3
lepodisiran sodium
lepodisiran sodium
Atherosclerosis
Eli Lilly and Co
Phase 2
lepunafusp alfa
lepunafusp alfa [INN]
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )
JCR Pharmaceuticals Co Ltd
Phase 2
lepzacitinib
lepzacitinib
Atopic Dermatitis (Atopic Eczema)
$ACRS
Aclaris Therapeutics, Inc.
Phase 2
lerapolturev
lerapolturev [INN]
Metastatic Melanoma
Istari Oncology Inc
Phase 2
leronlimab
leronlimab
Metabolic Dysfunction-Associated Steatohepatitis (MASH or…
$CYDY
CytoDyn Inc.
Phase 2
letetresgene autoleucel
letetresgene autoleucel
Myxoid Liposarcoma
US WorldMeds LLC
Marketed
letrozole + ribociclib succinate
Kisqali Femara (letrozole + ribociclib succinate)
Human Epidermal Growth Factor Receptor 2 Negative Breast…
$NVS
NOVARTIS AG
Marketed
leuprolide acetate ER
Eligard (leuprolide acetate)
Metastatic Prostate Cancer
Tolmar Pharmaceuticals Inc
Marketed
leuprolide acetate PR
Lupron Depot-PED (leuprolide acetate)
Central Precocious Puberty
$ABBV
AbbVie Inc.
Marketed
leuprolide acetate SR
Lutrate Depot (leuprolide acetate)
Prostate Cancer
InvaGen Pharmaceuticals Inc
Marketed
leuprolide mesylate
Camcevi (leuprolide mesylate)
Central Precocious Puberty
Foresee Pharmaceuticals Co Ltd
Marketed
levacetylleucine
Aqneursa (levacetylleucine)
Ataxia-Telangiectasia (Louis-Bar Syndrome)
IntraBio Ltd
Marketed
levalbuterol hydrochloride
Levalbuterol Hydrochloride
Bronchospasm
The Ritedose Corp
Marketed
levalbuterol tartrate
Xopenex HFA (levalbuterol tartrate)
Bronchospasm
Lupin Ltd
Marketed
levamlodipine maleate
Conjupri (levamlodipine maleate)
Hypertension
WraSer Pharmaceuticals LLC
Marketed
levetiracetam ER
Levetiracetam
Partial Seizure
Intellipharmaceutics Ltd
Marketed
levetiracetam ODT
Spritam (levetiracetam)
Generalized Seizures
Aprecia Pharmaceuticals LLC
Marketed
levobunolol hydrochloride
Levobunolol Hydrochloride Pacific (levobunolol hydrochloride)
Ocular Hypertension
Pacific Pharmaceuticals USA
Marketed
levocarnitine
Levocarnitine
Carnitine Deficiency
EastPharma Ltd
Preclinical
levodopa CR
levodopa
Parkinson's Disease
Synthonics Inc
Marketed
levofloxacin
Levofloxacin
Acute Bacterial Sinusitis
Teva Pharmaceuticals USA Inc
